| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.37 | 7e-08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |